BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration to request approval of its technetium-99m generator for medical imaging. A daughter isotope of molybdenum-99, Tc-99m is used in more than 40 million diagnostic procedures annually. BWXT Medical is a subsidiary of Lynchburg, Va.-based BWX Technologies.
BWXT advances on TRISO project
BWX Technologies (BWXT) has achieved a key milestone in its project to additively manufacture advanced forms of TRISO fuel for Generation IV advanced nuclear reactors. The Lynchburg Technology...
Maritime organizations to consult with the IAEA
The Nuclear Energy Maritime Organization (NEMO) recently announced that it was officially granted nongovernmental organization consultative status with the International Maritime Organization....
Canada clears Darlington to produce Lu-177 and Y-90
The Canadian Nuclear Safety Commission has amended Ontario Power Generation’s power reactor operating license for Darlington nuclear power plant to authorize the production of the medical...
TVA files for Clinch River SMR construction permit
The Tennessee Valley Authority announced yesterday that it has submitted a construction permit application to the Nuclear Regulatory Commission for the construction of a GE Vernova Hitachi...
BWXT acquires Oak Ridge site as NNSA pursues unobligated enriched uranium
BWX Technologies Inc. has purchased about 97 acres of land in an Oak Ridge, Tenn., industrial park where the company expects to build a uranium enrichment facility using a technology called...
Mizzou announces contract signing for NextGen MURR project
The University of Missouri announced today that it has signed a $10 million contract for the initial design phase of the $1 billion-plus state-of-the-art NextGen MURR research reactor project....
Ontario Power Generation issued license to build an SMR at Darlington
On track to be the first SMR constructed in North America
The Canadian Nuclear Safety Commission has announced its approval for Ontario Power Generation to construct a General Electric Hitachi BWRX-300 small modular reactor at its Darlington site in...
First astatine-labeled compound shipped in the U.S.
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound...
Nuclear News 40 Under 40 discuss the future of nuclear
Seven members of the inaugural Nuclear News 40 Under 40 came together on March 4 to discuss the current state of nuclear energy and what the future might hold for science, industry, and the...
OPG’s refurbished Darlington-1 begins Co-60 production
Ontario Power Generation in Canada announced that Unit 1 of its Darlington nuclear power plant, which has returned to service from refurbishment, is now producing the medical isotope...
